Journals / Anestezi Dergisi / 2017 / Cilt: 25 - Sayı: 3

A NEW GOAL IN OPIOID MANAGEMENT IN OBESE PATIENTS

OBEZ<TE HASTALARINDA OP<O<D YÖNET<M<NDE YEN< AMAÇ: OP<O<DS<Z ANESTEZ<

Pages
117–121
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this regard,opioid-free anaesthesia for obese population should be reserved for cautiously-selected patients and interventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Opioids have unique features that facilitate premedication, smooth induction, ease the maintenance of anaesthesia and improvepostoperative pain relief.
📊
Key Findings & Data:The drugs used for anopioid-free anaesthesia plan include, but are not limited to, ?-2 adrenergic receptor agonists, ketamine, lidocaine, gabapentinoidsand magnesium, separately or in combinations.
💡
Conclusion & Impact:In this regard,opioid-free anaesthesia for obese population should be reserved for cautiously-selected patients and interventions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Opioids have unique features that facilitate premedication, smooth induction, ease the maintenance of anaesthesia and improvepostoperative pain relief. However, they also have side effects such as respiratory depression, nausea and vomiting. Obesity is oneof the most frequent disorders that require attentive opioids management. The physiological and pathophysiological consequencesof opioids in obese population lead clinicians avoid or limit these drugs during anaesthetic management. The drugs used for anopioid-free anaesthesia plan include, but are not limited to, ?-2 adrenergic receptor agonists, ketamine, lidocaine, gabapentinoidsand magnesium, separately or in combinations. For opioid-free anaesthesia, clinicians should have thorough knowledge ofpharmacokinetic and pharmacodynamic properties of substitute drugs used instead of opioids. Anaesthesia depth should bemonitored. Minimally invasive surgery, experienced surgery and anaesthesia team help ensuring the success of this technique.Opioid-free anaesthesia is a new horizon for anaesthetists who try to perfect their practice in overweight patients. In this regard,opioid-free anaesthesia for obese population should be reserved for cautiously-selected patients and interventions.

Özet

Opioidler premedikasyonda, intraoperatif dönemde indüksiyon ve idamede ve postoperatif dönemde etkin analjeziuygulamalarında kendine yer bulan, ancak respiratuvar depresyon, bulantı kusma gibi yan etkileri de bulunan özellikli ilaçlardır.Obezite ise opioidlerinin yan etki profillerinin belirginleştiği bir yandaş hastalık olup, opioidlerin bu popülasyondaki fizyolojik vepatofizyolojik profilleri, klinisyenlerin anaestezi yönetimi sırasında opioidlerden kısmen veya tamamen uzaklaşmasına nedenolmaktadır. Opioidsiz anestezi uygulamasında kullanılan ilaçlar bunlarla sınırlı olmamakla beraber, sıklıkla ?-2 adrenerjik reseptöragonistleri, ketamin, lidokain, gabapentinoidler, magnezyum ve kombinasyonlarını içermektedir. Opioidsiz anestezi uygulamasıiçin anaestezistlerin opioidlerin yerine geçecek ilaçların obez hasta grubundaki farmakokinetik ve farmakodinamik özellikleriniiyi bilmeleri ve anestezi derinliğini monitorize etmeleri gerekmektedir. Minimal invazif cerrahi teknikleri, deneyimli cerrahi veanestezi ekipleri tekniğin başarısına katkı sağlayacaktır. Bu bağlamda, opoidsiz anestezi dikkatle seçilmiş hasta ve cerrahilerdetercih edilmelidir.

🔖

Cite This Article

ÇOK, O. Y. (2017). A NEW GOAL IN OPIOID MANAGEMENT IN OBESE PATIENTS. Anestezi Dergisi, Cilt: 25 - Sayı: 3, 117–121. https://ajindex.com/articles/152946

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Mulier JP. Perioperative opioids aggravate obstructive breathing in sleep apnea syndrome: mechanisms and alternative anesthesia strategies. Curr Opin Anaesthesiol 2016; 29: 129-133
  2. Seet E, Chung F. Management of sleep apnea in adults - functional algorithms for the perioperative period: Continuing Professional Development. Can J Anaesth. 2010; 57: 849-864
  3. Cullen A, Ferguson A. Perioperative management of the severely obese patient: a selective pathophysiological review. Can J Anaesth 2012; 59: 974-996
  4. Shapiro A, Zohar E, Zaslansky R, Hoppenstein D, Shabat S, Fredman B. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine. J Clin Anesth 2005; 17: 537-542
  5. Lee YY, Kim KH, Yom YH. Predictive models for post-operative nausea and vomiting in patients using patient-controlled analgesia. J Int Med Res 2007; 35: 497-507
  6. Ingrande J, Lemmens HJM. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth [Internet]. 2010; 105 (Supplement 1): i16-23
  7. La Colla L, Albertin A, La Colla G et al. Predictive performance of the "Minto" remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass. Clin Pharmacokinet 2010; 49: 131-139
  8. Slepchenko G, Simon N, Goubaux B, Levron J-C, Le Moing J-P, Raucoules-Aimé M. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology 2003; 98: 65-73
  9. Graves DA, Batenhorst RL, Bennett RL, Wettstein JG, Griffen WO, Wright BD, et al. Morphine requirements using patientcontrolled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm 1983; 2: 49-53
  10. Grodofsky SR, Sinha AC. The association of gender and body mass index with postoperative pain scores when undergoing ankle fracture surgery. J Anaesthesiol Clin Pharmacol 2014; 30: 248-252
  11. Shibutani K, Inchiosa MA, Sawada K, Bairamian M. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 2005; 95: 377-383
  12. Lloret-Linares C, Luo H, Rouquette A et al. The effect of morbid obesity on morphine glucuronidation. Pharmacol Res 2017; 118: 64-70
  13. Nafiu OO, Shanks A, Abdo S, Taylor E, Tremper TT. Association of high body mass index in children with early post-tonsillectomy pain. Int J Pediatr Otorhinolaryngol 2013; 77: 256-261
  14. Lloret Linares C, Hajj A, Poitou C et al. Pilot study examining the frequency of several g